Leo R - Search Results

1

Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma.

Bisping G, Leo R, Wenning D, Dankbar B, Padró T, Kropff M, Scheffold C, Kröger M, Mesters RM, Berdel WE, Kienast J. Bisping G, et al. Among authors: leo r. Blood. 2003 Apr 1;101(7):2775-83. doi: 10.1182/blood-2002-09-2907. Epub 2002 Nov 27. Blood. 2003. PMID: 12517814 Free article.

2

Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma.

Dankbar B, Padró T, Leo R, Feldmann B, Kropff M, Mesters RM, Serve H, Berdel WE, Kienast J. Dankbar B, et al. Among authors: leo r. Blood. 2000 Apr 15;95(8):2630-6. Blood. 2000. PMID: 10753844 Free article.

3

Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells.

Fenski R, Flesch K, Serve S, Mizuki M, Oelmann E, Kratz-Albers K, Kienast J, Leo R, Schwartz S, Berdel WE, Serve H. Fenski R, et al. Among authors: leo r. Br J Haematol. 2000 Feb;108(2):322-30. doi: 10.1046/j.1365-2141.2000.01831.x. Br J Haematol. 2000. PMID: 10691863 Free article.

4

Effect of interleukin-2 on the ex vivo growth of human myeloma cells.

Peest D, de Vries I, Hölscher R, Leo R, Deicher H. Peest D, et al. Among authors: leo r. Cancer Immunol Immunother. 1989;30(4):227-32. doi: 10.1007/BF01665009. Cancer Immunol Immunother. 1989. PMID: 2532059 Free PMC article.

5

CD16- CD56+ natural killer cells after bone marrow transplantation.

Jacobs R, Stoll M, Stratmann G, Leo R, Link H, Schmidt RE. Jacobs R, et al. Among authors: leo r. Blood. 1992 Jun 15;79(12):3239-44. Blood. 1992. PMID: 1375847 Free article.

6

Tumor-directed cytotoxicity in multiple myeloma--the basis for an experimental treatment approach with interleukin 2.

Peest D, Leo R, Deicher H. Peest D, et al. Among authors: leo r. Stem Cells. 1995 Aug;13 Suppl 2:72-6. Stem Cells. 1995. PMID: 8520515 Review.

7

Low-dose recombinant interleukin-2 therapy in advanced multiple myeloma.

Peest D, Leo R, Bloche S, Hein R, Stannat-Kiessling S, Tschechne B, Fett W, Harms P, Hoffmann L, Bartl R, et al. Peest D, et al. Among authors: leo r. Br J Haematol. 1995 Feb;89(2):328-37. doi: 10.1111/j.1365-2141.1995.tb03308.x. Br J Haematol. 1995. PMID: 7873383 Clinical Trial.

8

Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells.

Sahota SS, Leo R, Hamblin TJ, Stevenson FK. Sahota SS, et al. Among authors: leo r. Blood. 1997 Jan 1;89(1):219-26. Blood. 1997. PMID: 8978295 Free article.

9

Ig VH gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance.

Sahota SS, Leo R, Hamblin TJ, Stevenson FK. Sahota SS, et al. Among authors: leo r. Blood. 1996 Jan 15;87(2):746-55. Blood. 1996. PMID: 8555499 Free article.

10

Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells.

Leo R, Boeker M, Peest D, Hein R, Bartl R, Gessner JE, Selbach J, Wacker G, Deicher H. Leo R, et al. Ann Hematol. 1992 Mar;64(3):132-9. doi: 10.1007/BF01697400. Ann Hematol. 1992. PMID: 1373957

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters